129 related articles for article (PubMed ID: 3681244)
21. Carcinoembryonic antigen (CEA) in human colorectal cancers growing subcutaneously in nude mice.
Fiebig HH; von Kleist S
J Cancer Res Clin Oncol; 1983; 105(3):238-42. PubMed ID: 6853586
[TBL] [Abstract][Full Text] [Related]
22. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
[TBL] [Abstract][Full Text] [Related]
23. The biological and clinical significance of tumor markers in tissue extracts.
Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
[TBL] [Abstract][Full Text] [Related]
25. Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients.
Jessup JM; Giavazzi R; Campbell D; Cleary K; Morikawa K; Fidler IJ
Cancer Res; 1988 Mar; 48(6):1689-92. PubMed ID: 3345536
[TBL] [Abstract][Full Text] [Related]
26. [CEA determination in the follow-up of colorectal cancers].
Lauterbach M; Dehne A; Hesse V; Höfig G
Zentralbl Chir; 1987; 112(15):968-74. PubMed ID: 3673304
[TBL] [Abstract][Full Text] [Related]
27. Faecal carcinoembryonic antigen (CEA) in patients with large bowel cancer.
Stubbs RS; Nadkarni DM; Monsey HA
Eur J Surg Oncol; 1987 Oct; 13(5):433-6. PubMed ID: 3666160
[TBL] [Abstract][Full Text] [Related]
28. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
29. Serum glycosyl transferases and carcinoembryonic antigen in patients with colorectal carcinoma in different stages.
Ronquist G; Rimsten A; Blanche C; Cervén E; Hiesche C; Westman M
Acta Chir Scand; 1982; 148(4):373-7. PubMed ID: 7136442
[No Abstract] [Full Text] [Related]
30. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer.
Goslin R; O'Brien MJ; Steele G; Mayer R; Wilson R; Corson JM; Zamcheck N
Am J Med; 1981 Aug; 71(2):246-53. PubMed ID: 6167166
[TBL] [Abstract][Full Text] [Related]
31. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
Koch M; Washer G; Gaedke H; McPherson TA
J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
[TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen in prognosis of colorectal cancer.
N Engl J Med; 1978 Dec; 299(24):1369-70. PubMed ID: 714113
[No Abstract] [Full Text] [Related]
33. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
[TBL] [Abstract][Full Text] [Related]
34. [Use of the carcinoembryonic antigen in the diagnosis of colorectal cancer].
Simici P; Popa F; Păunescu V; Herşcovici H
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(1):57-64. PubMed ID: 3158035
[No Abstract] [Full Text] [Related]
35. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
[TBL] [Abstract][Full Text] [Related]
36. [Immunologic findings in patients with colorectal carcinoma. V. CEA in colorectal carcinoma. Comparison with the activity of biological markers of malignancy].
Richter J; Král V; Hrbek M
Rozhl Chir; 1986 Jul; 65(7):533-6. PubMed ID: 3764590
[No Abstract] [Full Text] [Related]
37. A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms.
Cooper MJ; Mackie CR; Skinner DB; Moossa AR
Br J Surg; 1979 Feb; 66(2):120-3. PubMed ID: 420982
[TBL] [Abstract][Full Text] [Related]
38. Tissue CEA detection by immunoperoxidase (PAP) test in colorectal polyps: correlations with the degree of dysplasia.
Amanti C; Midiri G; Benedetti M; Campisi C; Di Tondo U; Castagna G; Peronace L; Santeusanio G; Di Paola M
J Surg Oncol; 1985 Mar; 28(3):222-6. PubMed ID: 3883061
[TBL] [Abstract][Full Text] [Related]
39. The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer.
Steele G; Zamcheck N
Cancer Detect Prev; 1985; 8(3):421-7. PubMed ID: 4064062
[TBL] [Abstract][Full Text] [Related]
40. [Practical applications of the radioimmunoassay of carcinoembryonic antigen (CEA) in the follow-up of colo-rectal carcinoma patients].
Mach JP; Jeager P; Vienny H; Meyer A; Pettavel J
Schweiz Rundsch Med Prax; 1979 Jun; 68(26):856-63. PubMed ID: 542458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
